The Ultimate Guide To SUPPLEMENT PROTOCOL
below both Drake’s and Lynch’s versions, the expense of deleterious mutations is exactly what drives mutation prices down (Drake 1991; Lynch 2010; Sung et al. 2012). Therefore, under both of those models, a rise in the normal expense of mutations would bring about a lessen in mutation rates. To exam